Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics in morbid obesity after bariatric surgery
2009-013156-72Phase 4Active
- Sponsor
- IMAS
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dextromethorphan, omeprazole, losartan, acetaminophen and caffeine in class III obesity (2 arms), sponsored by IMAS. Primary endpoint: Plasma and urinary concentrations of probe drugs, metabolites, and endogenous markers. Started Aug 2009; status: active.
02
Drugs
dextromethorphanomeprazolelosartanacetaminophencaffeine
03
Conditions
class III obesity
Beyond the preview
Go deeper on 2009-013156-72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013156-72.